E71.1

Clinical Causes: Genetic mutations affecting enzymes involved in BCAA metabolism. Inheritance patterns typically autosomal recessive, meaning both copies of a gene must be affected. Enzyme deficiencies that impair the breakdown of leucine, isoleucine, and valine. Potential environmental factors that may influence severity, although the primary cause is genetic.

Key Symptoms: Poor feeding and difficulties gaining weight in infants. Developmental delays or regression in some cases. Muscle weakness or tone abnormalities. Lethargy or reduced activity levels. Episodes of metabolic crisis characterized by vomiting, dehydration, or altered consciousness. Elevated levels of BCAAs in blood tests may also be observed.

Diagnosis Path: Diagnosis typically involves a combination of medical history, clinical examination, and laboratory tests. Key components include: - Blood tests to measure amino acid levels, which often reveal elevated BCAAs. - Urine tests for organic acid analysis. - Enzyme activity assays to identify specific enzyme deficiencies. - Genetic testing to detect mutations associated with BCAA metabolism disorders. Early detection is crucial for managing the condition and preventing complications.

Treatment Protocols: Managing disorders of branched-chain amino acid metabolism focuses on preventing metabolic crises and supporting normal development. Approaches include: - Dietary restrictions to limit intake of BCAAs, tailored by a metabolic specialist. - Specialized formulas or medical foods formulated to control amino acid intake. - Regular monitoring of blood amino acid levels. - Prompt treatment during illness or metabolic stress to prevent symptoms from worsening. - In some cases, medications may be used to support enzyme function or facilitate amino acid metabolism. - Long-term management involves a multidisciplinary team, including metabolic specialists, dietitians, and neurologists, to optimize quality of life and developmental outcomes.